Mixed Results Announced for Trehalose in ALS Study : vimarsa

Topline data were announced from the phase 2/3 HEALEY ALS Platform trial evaluating SLS-005 for amyotrophic lateral sclerosis (ALS).

Related Keywords

, Drug Administration , Transcription Factor , Rating Scale , Full Analysis Set , Efficacy Relyvrio Free , Raj Mehra Phd , Orphan Drug ,